Injectable HIV Treatment Offers Hope to Ugandan Patients
About 200 patients in Uganda began in October of last year a trial of a World Health Organization-approved injection containing the drugs cabotegravir, or CAB-LA, and rilpivirine. Results are due in 2024. The treatment, developed by British drug maker GlaxoSmithKline is the first non-pill option against HIV, and studies have shown it even outperforms the efficacy of oral pills.
Episodes
-
![Commonwealth of Nations’ chief wraps up 9-year tenure]()
March 15, 2025Commonwealth of Nations’ chief wraps up 9-year tenure
-
![US officials hold talks with DRC as rebels advance]()
March 14, 2025US officials hold talks with DRC as rebels advance
